Radiosynthesis of racemic and enantiomerically pure (-)-[18F]flubatine-A promising PET radiotracer for neuroimaging of α4β2 nicotinic acetylcholine receptors

被引:18
作者
Fischer, Steffen [1 ]
Hiller, Achim [1 ]
Smits, Rene [2 ]
Hoepping, Alexander [2 ]
Funke, Uta [1 ]
Wenzel, Barbara [1 ]
Cumming, Paul [2 ]
Sabri, Osama [3 ]
Steinbach, Joerg [1 ]
Brust, Peter [1 ]
机构
[1] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharm, Dept Neuroradiopharmaceut, D-04318 Leipzig, Germany
[2] ABX Adv Biochem Cpds GmbH, D-01454 Radeberg, Germany
[3] Univ Leipzig, Dept Nucl Med, D-04103 Leipzig, Germany
关键词
Fluorine-18; Neuroirnaging; alpha(4)beta(2) nAChR ligands; Radiosynthesis; Leaving groups; Protecting groups; ALZHEIMERS-DISEASE; EPIBATIDINE; RADIOLIGANDS; AVAILABILITY; F-18-NIFENE; ANALOGS; BINDING;
D O I
10.1016/j.apradiso.2013.01.002
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
(-)-[F-18]flubatine is a promising agent for visualization by PET of cerebral alpha(4)beta(2) nicotinic acetylcholine receptors (nAChRs), which are implicated in psychiatric and neurodegenerative disorders. Here, we describe a substantially improved two-step radiosynthesis strategy for (-)-[F-18]flubatine, based on the nucleophilic radiofluorination of an enantiomerically pure precursor followed by deprotection of the intermediate. An extensive leaving group/protecting group library of precursors was tested. Application of a trimethylammonium-iodide precursor with a Boc-protecting group provided the best results: labeling efficiencies of 80-95%, RCY of 60 +/- 5%, radiochemical purity of >98%, and a specific activity of > 350 GBq/mu mol. The radiosynthesis is easily transferable to an automated synthesis module. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:128 / 136
页数:9
相关论文
共 40 条
  • [1] The projected effect of risk factor reduction on Alzheimer's disease prevalence
    Barnes, Deborah E.
    Yaffe, Kristine
    [J]. LANCET NEUROLOGY, 2011, 10 (09) : 819 - 828
  • [2] Imaging of cholinergic and monoaminergic neurochemical changes in neurodegenerative disorders
    Bohnen, Nicolaas I.
    Frey, Kirk A.
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2007, 9 (04) : 243 - 257
  • [3] In vivo measurement of nicotinic acetylcholine receptors with [18F]norchloro-fluoro-homoepibatidine
    Brust, Peter
    Patt, Joerg Thomas
    Deuther-Conrad, Winnie
    Ecker, Georg
    Patt, Marianne
    Schildan, Andreas
    Sorger, Dietlind
    Kendziorra, Kai
    Meyer, Philipp
    Steinbach, Joerg
    Sabri, Osama
    [J]. SYNAPSE, 2008, 62 (03) : 205 - 218
  • [4] 9-FLUORENYLMETHOXYCARBONYL AMINO-PROTECTING GROUP
    CARPINO, LA
    HAN, GY
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1972, 37 (22) : 3404 - &
  • [5] EPIBATIDINE ANALOGS SYNTHESIZED FOR CHARACTERIZATION OF NICOTINIC PHARMACOPHORES-A REVIEW
    Carroll, F. Ivy
    [J]. HETEROCYCLES, 2009, 79 : 99 - 120
  • [6] Chan W., 1999, Fmoc solid phase peptide synthesis: a practical approach
  • [7] β2-Nicotinic Acetylcholine Receptor Availability During Acute and Prolonged Abstinence From Tobacco Smoking
    Cosgrove, Kelly P.
    Batis, Jeffery
    Bois, Frederic
    Maciejewski, Paul K.
    Esterlis, Irina
    Kloczynski, Tracy
    Stiklus, Stephanie
    Krishnan-Sarin, Suchitra
    O'Malley, Stephanie
    Perry, Edward
    Tamagnan, Gilles
    Seibyl, John P.
    Staley, Julie K.
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2009, 66 (06) : 666 - 676
  • [8] Lower β2*-Nicotinic Acetylcholine Receptor Availability in Smokers With Schizophrenia
    D'Souza, Deepak Cyril
    Esterlis, Irina
    Carbuto, Michelle
    Krasenics, Maegan
    Seibyl, John
    Bois, Frederic
    Pittman, Brian
    Ranganathan, Mohini
    Cosgrove, Kelly
    Staley, Julie
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2012, 169 (03) : 326 - 334
  • [9] Norchloro-fluoro-homoepibatidine (NCFHEB) - A promising radioligand for neuroimaging nicotinic acetylcholine receptors with PET
    Deuther-Conrad, W.
    Patt, J. T.
    Lockman, P. R.
    Allen, D. D.
    Patt, M.
    Schildan, A.
    Ganapathy, V.
    Steinbach, J.
    Sabri, O.
    Brust, P.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 (03) : 222 - 229
  • [10] Deuther-Conrad Winnie, 2004, Farmaco (Lausanne), V59, P785, DOI 10.1016/j.farmac.2004.07.004